It has been reported that ADCY1 can induce β-cell dysfunction in pancreatic cancer; it is a significant diagnostic and prognostic biomarker for pancreatic adenocarcinoma [24,38]. This evidence concerns the gene ADCY1 and pancreatic neoplasm.